Advances in Treatment and Prevention of HIV

Timothy J Hatlen¹, Rachel Bender Ignacio^{2

3}, Eric S Daar¹

Affiliations

¹ Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
² Division of Allergy and Infectious Diseases, University of Washington, Seattle.
³ Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, Washington.

Timothy J Hatlen et al. JAMA. 2025.

. 2025 Feb 18;333(7):576-578.

doi: 10.1001/jama.2024.24027.

Timothy J Hatlen¹, Rachel Bender Ignacio^{2

3}, Eric S Daar¹

¹ Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
² Division of Allergy and Infectious Diseases, University of Washington, Seattle.
³ Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, Washington.

No abstract available

Comment in

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, Günthard HF, Thompson MA, Bedimo RJ, Benson CA, Buchbinder SP, Crabtree-Ramirez BE, Del Rio C, Eaton EF, Eron JJ Jr, Hoy JF, Lehmann C, Molina JM, Jacobsen DM, Saag MS. Gandhi RT, et al. JAMA. 2025 Feb 18;333(7):609-628. doi: 10.1001/jama.2024.24543. JAMA. 2025. PMID: 39616604